Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds – The Washington Post

1. Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds  The Washington Post
2. Covid-19 vaccine for 5- to 11-year-olds is safe and shows ‘robust’ antibody response, Pfizer says  CNN
3. Covid Vaccine Prompts Strong Immune Response in Younger Children, Pfizer Says  The New York Times
4. Covid-19 and how we can boost our way forward  Independent.ie
5. More US-made vaccines coming  Philstar.com
6. View Full Coverage on Google News

Source: Low dose of Pfizer-BioNTech vaccine is safe and effective in children ages 5 to 11, companies’ study finds – The Washington Post